Life Sciences organizations face growing pressure to generate real-world evidence (RWE) faster and at greater scale—for internal decision-making, publication, and external stakeholders, including regulators and payers.Speed is now non-negotiable, but scientific rigor cannot be sacrificed.As… Continue reading →